AR047716A1 - Combinaciones de analepticos y antidepresivos - Google Patents

Combinaciones de analepticos y antidepresivos

Info

Publication number
AR047716A1
AR047716A1 ARP040101626A ARP040101626A AR047716A1 AR 047716 A1 AR047716 A1 AR 047716A1 AR P040101626 A ARP040101626 A AR P040101626A AR P040101626 A ARP040101626 A AR P040101626A AR 047716 A1 AR047716 A1 AR 047716A1
Authority
AR
Argentina
Prior art keywords
analeptic
antidepressive
combinations
modafinil
antidepressant
Prior art date
Application number
ARP040101626A
Other languages
English (en)
Inventor
Howard Hassman
Rodney J Hughes
Original Assignee
Cephalon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cephalon Inc filed Critical Cephalon Inc
Publication of AR047716A1 publication Critical patent/AR047716A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Abstract

Composiciones y métodos para el tratamiento de trastornos depresivos mediante administracion de modafinilo con antidepresivos. Método para aumentar la actividad de un antidepresivo mediante la administracion de modafinilo.
ARP040101626A 2003-05-13 2004-05-14 Combinaciones de analepticos y antidepresivos AR047716A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46998903P 2003-05-13 2003-05-13
US10/844,134 US20040229941A1 (en) 2003-05-13 2004-05-12 Analeptic and antidepressant combinations

Publications (1)

Publication Number Publication Date
AR047716A1 true AR047716A1 (es) 2006-02-15

Family

ID=33423938

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040101626A AR047716A1 (es) 2003-05-13 2004-05-14 Combinaciones de analepticos y antidepresivos

Country Status (4)

Country Link
US (1) US20040229941A1 (es)
AR (1) AR047716A1 (es)
TW (1) TW200509895A (es)
WO (1) WO2004100940A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001283008A1 (en) * 2000-07-27 2002-02-13 Teva Pharmaceutical Industries Ltd. Crystalline and pure modafinil, and process of preparing the same
US6992219B2 (en) * 2002-08-09 2006-01-31 Cephalon France Modafinil polymorphic forms
AR045314A1 (es) * 2003-05-13 2005-10-26 Cephalon Inc Composiciones farmaceuticas de analepticos y antidepresivos
US20040242698A1 (en) * 2003-05-13 2004-12-02 Cephalon Inc. Analeptic and antidepressant combinations
AR045423A1 (es) * 2003-05-13 2005-10-26 Cephalon Inc Combinaciones de analiticos y antidepresivos
US20040229943A1 (en) * 2003-05-16 2004-11-18 Cephalon Inc Analeptic and drug combinations
US7368591B2 (en) 2003-09-19 2008-05-06 Cephalon France Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation
WO2008003093A2 (en) * 2006-06-29 2008-01-03 Questcor Pharmaceuticals, Inc. Pharmaceutical compositions and related methods of treatment
EP2125017A2 (en) * 2007-01-11 2009-12-02 Braincells, Inc. Modulation of neurogenesis with use of modafinil

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2593809B1 (fr) * 1986-01-31 1988-07-22 Lafon Labor Benzhydrylsulfinylacetamide, procede de preparation et utilisation en therapeutique
FR2771004B1 (fr) * 1997-11-19 2000-02-18 Inst Curie Utilisation de derives de benzhydryl sulfinyle pour la fabrication de medicaments ayant un effet eveillant dans des situations de troubles de la vigilance d'origine medicamenteuse
WO2001013921A1 (en) * 1999-08-23 2001-03-01 Ockert David M Triple drug therapy for the treatment of narcotic and alcohol withdrawal symptoms
AR045314A1 (es) * 2003-05-13 2005-10-26 Cephalon Inc Composiciones farmaceuticas de analepticos y antidepresivos
US20040242698A1 (en) * 2003-05-13 2004-12-02 Cephalon Inc. Analeptic and antidepressant combinations
AR045423A1 (es) * 2003-05-13 2005-10-26 Cephalon Inc Combinaciones de analiticos y antidepresivos

Also Published As

Publication number Publication date
TW200509895A (en) 2005-03-16
US20040229941A1 (en) 2004-11-18
WO2004100940B1 (en) 2005-01-13
WO2004100940A1 (en) 2004-11-25

Similar Documents

Publication Publication Date Title
NO20055448L (no) Kombinasjon av et analeptisk modafinil og en antidepressiv forbindelse for behandling av depresjon
ECSP077280A (es) Moduladores de quinasa de pirrolo-piridina
UY28862A1 (es) Nuevas composiciones farmaceuticas para el tratamiento de los trastornos sexuales ii
NO20055450L (no) Kombinasjon av et analeptisk modafinili og en antidepressiv forbindelse for behandling av depresjon
CR8118A (es) Aril y heteroaril derivados fusionados como moduladores del metabolismo y la prevencion y tratamiento de trastornos relacionados con el mismo
CL2011002209A1 (es) Compuestos derivados de 2-mercaptoquinolin-3-carboxamida; medicamento que los comprende; y uso para tratar el dolor, epilepsia, incontinencia urinaria, ansiedad, dependencia manias, transtornos bipolares, migraña, enfermedades cognitivas, discinesia asociada a la distonia y/o incontinencia urinaria.
UY28945A1 (es) Derivados de pirrolopiridina
EA202092720A1 (ru) Способ увеличения биологической доступности и степени воздействия активатора потенциалзависимых калиевых каналов
EA200701300A1 (ru) Амидное пролекарство гемцитабина, композиции на его основе и его применение
CL2007003065A1 (es) Compuestos derivados de benzodioxano, agonista 5ht2c, composicion farmaceutica que lois comprende; y sus uso en el tratamiento de un trastorno psicotico, ansiedad, depresion, trastorno bipolar, sindrome premenstrual, entre otros
EA200601390A1 (ru) Композиции модафинила
EA200802072A1 (ru) Ликопин для лечения нарушения обмена веществ
CL2011002766A1 (es) Compuestos derivados de carboxamida, inhibidores de calpaina; composicion farmaceutica que los comprende; y su uso en el tratamiento de enfermedades neurodegenerativas, alzahimer, dolor, entre otras.
EA202091020A1 (ru) Замещенные имидазопиридинамиды и их применение
CL2011002160A1 (es) Compuestos derivados de 3-amino-2-mercaptoquinolinas sustituidas; composicion farmaceutica que contiene dichos compuestos; y su uso para tratar dolor, epilepsis, incontinencia urinaria, manias, migraña, trastornos bipolares, enfermedades cognitivas, discinesia asociada a la distonia y/o incontinencia urinaria.
AR047716A1 (es) Combinaciones de analepticos y antidepresivos
CL2012000097A1 (es) Compuestos derivados de 3-fenoximetilpirrolidina, inhibidores de la recaptacion de serotonina-norepinefrina; procedimiento de preparacion; compuestos intermediarios; composicion farmaceutica que lo comprende; y su uso en el tratamiento de trastornos del dolor, depresion, entre otros.
TW200509896A (en) Analeptic and drug combinations
CL2021002318A1 (es) Métodos de tratamiento de amiloidosis al
TW200509894A (en) Analeptic and antidepressant combinations
MX2011012596A (es) Metodos para incrementar os efectos de un inhibidor selectivo de la recaptacion de serotonina en los mamiferos.
AR057277A1 (es) Utilizacion de agomelatina para la obtencion de medicamentos destinados al tratamiento de los trastornos bipolares
EA200970368A1 (ru) Новый кристалл (s)-(+)-2-(2-хлорфенил)-2-гидроксиэтилкарбамата
CL2004001042A1 (es) Metodo para aumentar la actividad de un antidepresivo en un sujeto animal que consiste en tratar al sujeto con modafinilo.
CL2004001040A1 (es) Uso de modafinilo para preparar un medicamento util para tratar un desorden depresivo.

Legal Events

Date Code Title Description
FB Suspension of granting procedure